Matthew W. Bending

Biography

Matthew has led the development of early payer engagement services in Mapi and has experience of more than 25 HTA scientific advice engagements across a range of disease areas. Matthew provides senior leadership for large projects on strategic market access and Health Technology Assessments (HTAs) for pharmaceutical, vaccine, and medical device companies. His experience is wide-ranging, from projects for international HTA submissions, HTA scientific advice, value proposition development, market access, systematic literature reviews, economic models, payer advisory boards, and global value dossiers. Prior to joining Mapi, Matthew was a Senior Consultant at York Health Economics Consortium, working on projects for the National Institute for Health and Care Excellence, Department of Health, Patient Safety Research Portfolio, and more. Matthew has a PhD in Health Sciences from the University of York and his thesis explored the use of HTA in international reimbursement decision-making. He also has an MSc and BSc honours in Economics from the University of Warwick. Matthew Bending completed a PhD fellowship on the use of Health Economic Analysis in OECD countries’ pharmaceutical systems and its contribution to decision-making. He has presented at international conferences, published over 30 reports/papers, and been involved in more than 100 HEOR and market access consulting projects. Dr. Bending was a co-author of a study that won the Egon Jonsson price in 2009/2010 for most outstanding paper published in the International Journal of Technology Assessment in Health Care: Trueman, P., Hurry, M., Bending, M. W. & Hutton, J. 2009. The feasibility of harmonizing health technology assessments across jurisdictions: A case study of drug eluting stents. International Journal of Technology Assessment in Health Care, 25, 455-462.

Research Interest

pharmaceutical, vaccine, and medical